1. Stocks
  2. Kymera Therapeutics Inc
  3. Swot
swot-logo

Kymera Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Kymera Therapeutics Inc has 18 Strengths, 9 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout Third Resistance ( LTP > R3)

Strong Momentum: Price above short, medium and long term moving averages

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over the Quarter (3 Months)

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Positive Breakout (LTP > R2)

Positive breakout third resistance ( LTP > R3)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Positive Breakout (LTP > R1)

High Volume, High Gain

Top Gainers

Stock with Low PE (PE < = 10)

Volume Shockers

High Volume, High Gain

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Low DVM Stocks - Stocks to Exercise Caution On

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low durability companies

Weak Stocks (DVM)

Inefficient use of shareholder funds - ROE declining in the last 2 years

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month